Cancer Genetics (CGIX) Stock Climbs 45% This Week: How Does it Score?

 

Cancer Genetics Inc (CGIX) stock is up 45% this week. CGIX stock has fallen -82.42% over the last 12 months, and the average rating from Wall Street analysts is a Hold. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives CGIX stock a score of 46 out of a possible 100.

That score is chiefly influenced by a fundamental score of 10. CGIX’s score also includes a short-term technical score of 60. The long-term technical score for CGIX is 68.

Click Here to get the full Stock Score Report on Cancer Genetics Inc (CGIX).

What’s Happening with CGIX Stock Today

Cancer Genetics Inc (CGIX) stock has gained 5.23% while the S&P 500 has fallen -0.84% as of 12:49 PM on Tuesday, Oct 8. CGIX is higher by $0.01 from the previous closing price of $0.15 on volume of 12,399,921 shares. Over the past year the S&P 500 has gained 1.02% while CGIX has fallen -82.42%. CGIX lost -$0.75 per share in the over the last 12 months.

Symbols: CGIX

You May Also Like